Prognosis in infiltrating lobular carcinoma. An analysis of "classical" and variant tumors - PubMed (original) (raw)
Prognosis in infiltrating lobular carcinoma. An analysis of "classical" and variant tumors
D DiCostanzo et al. Am J Surg Pathol. 1990 Jan.
Abstract
A precise histologic and clinical delineation of infiltrating lobular carcinoma, including its variant forms, has been elusive. We studied 230 patients with stage I and II infiltrating lobular carcinoma treated by mastectomy and axillary lymph node dissection. Included were 176 patients with the "classical" or "Indian-file" pattern (IFL) of infiltrating lobular carcinoma, and 54 patients with variant (VAR) histology [solid (SOL), alveolar (ALV), and mixed (MIX) patterns]. IFL patients were younger than VAR patients (52 versus 57 years; p = 0.004), and IFL patients were more likely to be premenopausal (p = 0.013). Microscopic multifocality and intraepithelial ductular extension of LCIS were both more frequent in the IFL group (p = 0.008 and 0.03, respectively). There was no significant difference in tumor size (T1 versus T2), axillary lymph node status, or TNM stage at presentation. Median survival time and time to recurrence was similar in the two groups. Although it was not statistically significant, median survival for stage I and low-axillary lymph node positive stage II IFL patients was better than that of VAR patients. One hundred forty of our 176 IFL patients (80%) could be matched with infiltrating duct carcinoma (IFDC) patients of similar age at diagnosis, menstrual status, tumor size, and axillary lymph node involvement. When stratified by stage, stage I IFL patients had a significantly higher disease-free survival (p = 0.02) than comparable patients with IFDC. There was not a significant difference in disease-free survival when stage II IFL and IFDC patients were compared. The unmodified term "infiltrating lobular carcinoma" should be restricted to lesions exhibiting the classical or Indian-file (IFL) microscopic architectural pattern in approximately 85% of the tumor. Patients with VAR forms of IFL may have a less favorable prognosis and should be distinguished from those with classical IFL for further characterization.
Similar articles
- [Lobular invasive breast cancer prognostic factors: About 940 patients].
Jauffret C, Houvenaeghel G, Classe JM, Garbay JR, Giard S, Charitansky H, Cohen M, Bélichard C, Faure C, Darai É, Hudry D, Azuar P, Villet R, Gimbergues P, Tunon de Lara C, Martino M, Coutant C, Dravet F, Chauvet MP, Chéreau Ewald E, Penault-Llorca F, Goncalves A, Lambaudie É. Jauffret C, et al. Gynecol Obstet Fertil. 2015 Nov;43(11):712-7. doi: 10.1016/j.gyobfe.2015.09.007. Epub 2015 Oct 16. Gynecol Obstet Fertil. 2015. PMID: 26482833 French. - Prognosis in stage II (T1N1M0) breast cancer.
Rosen PP, Saigo PE, Braun DW, Weathers E, Kinne DW. Rosen PP, et al. Ann Surg. 1981 Nov;194(5):576-84. doi: 10.1097/00000658-198111000-00005. Ann Surg. 1981. PMID: 6271083 Free PMC article. - An evaluation of differences in prognosis, recurrence patterns and receptor status between invasive lobular and other invasive carcinomas of the breast.
du Toit RS, Locker AP, Ellis IO, Elston CW, Nicholson RI, Robertson JF, Blamey RW. du Toit RS, et al. Eur J Surg Oncol. 1991 Jun;17(3):251-7. Eur J Surg Oncol. 1991. PMID: 1646127 Clinical Trial. - Correlation of tumor size and axillary lymph node involvement with prognosis in patients with T1 breast carcinoma.
Abner AL, Collins L, Peiro G, Recht A, Come S, Shulman LN, Silver B, Nixon A, Harris JR, Schnitt SJ, Connolly JL. Abner AL, et al. Cancer. 1998 Dec 15;83(12):2502-8. Cancer. 1998. PMID: 9874455 Review. - Lobular carcinoma of the breast in situ and infiltrating.
Wheeler JE, Enterline HT. Wheeler JE, et al. Pathol Annu. 1976;11:161-88. Pathol Annu. 1976. PMID: 188001 Review.
Cited by
- Cytological characteristics of invasive lobular carcinoma of the human breast.
Tsuchiya S. Tsuchiya S. Med Mol Morphol. 2008 Sep;41(3):121-5. doi: 10.1007/s00795-008-0408-9. Epub 2008 Sep 20. Med Mol Morphol. 2008. PMID: 18807136 Review. - Clinical outcome in pleomorphic lobular carcinoma: a case-control study with comparison to classic invasive lobular carcinoma.
Narendra S, Jenkins SM, Khoor A, Nassar A. Narendra S, et al. Ann Diagn Pathol. 2015 Apr;19(2):64-9. doi: 10.1016/j.anndiagpath.2015.01.005. Epub 2015 Jan 22. Ann Diagn Pathol. 2015. PMID: 25682191 Free PMC article. - Invasive lobular carcinoma of the breast: A special histological type compared with invasive ductal carcinoma.
Chen Z, Yang J, Li S, Lv M, Shen Y, Wang B, Li P, Yi M, Zhao X, Zhang L, Wang L, Yang J. Chen Z, et al. PLoS One. 2017 Sep 1;12(9):e0182397. doi: 10.1371/journal.pone.0182397. eCollection 2017. PLoS One. 2017. PMID: 28863134 Free PMC article. - The basic pathology of human breast cancer.
Mallon E, Osin P, Nasiri N, Blain I, Howard B, Gusterson B. Mallon E, et al. J Mammary Gland Biol Neoplasia. 2000 Apr;5(2):139-63. doi: 10.1023/a:1026439204849. J Mammary Gland Biol Neoplasia. 2000. PMID: 11149570 Review. - Aspects of molecular phenotype and its correlations with breast cancer behaviour and taxonomy.
Hanby AM. Hanby AM. Br J Cancer. 2005 Feb 28;92(4):613-7. doi: 10.1038/sj.bjc.6602421. Br J Cancer. 2005. PMID: 15700031 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical